The DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Hepatocyte transplantation in acute liver failure
Abstract
The majority of patients with acute liver failure (ALF) die waiting for orthotopic liver transplantation (OLT). No other treatment modality is shown to improve survival. This study was conducted to assess the safety and feasibility of hepatocyte transplantation (HT) and subsequent engraftment and function of donor cells. Functional and structural integrity of cryopreserved and thawed human hepatocytes were assessed by their morphological characteristics, induction of P-4501A1 transcription, and survival in vivo by xenotransplantation into rats. Five patients with severe ALF underwent intrasplenic (4 patients) and/or intrahepatic (2 patients) HT through angiography under cyclosporine immunosuppression. All patients had grade III to IV encephalopathy and factor V levels less than 0.5 U/mL, were ventilator and dialysis dependent, and were not OLT candidates. Three of the 5 patients who survived 48 hours after HT had substantial improvement in encephalopathy scores, arterial ammonia levels, and prothrombin times. Clinical improvement was paralleled by an increase in aminopyrine and caffeine clearances. All 3 patients lived substantially longer than expected based on clinical experience after HT (12, 28, and 52 days) but eventually died. Postmortem examination showed the presence of transplanted hepatocytes in liver and spleen by light microscopy and fluorescent in situ hybridization (FISH). Cryopreserved and thawed human hepatocytes can be transplanted into recipients with ALF with some acceptable but definite complications. Engraftment of donor hepatocytes was proven by histological examination and FISH by both transjugular biopsy and at autopsy. Improvement in brain edema, encephalopathy grade, and clearance of antipyrine and caffeine suggested function, albeit with a 24- to 72-hour delay posttransplantation. (Liver Transpl 2000;6:32-40.)
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
HIGH-YIELD PREPARATION OF ISOLATED RAT LIVER PARENCHYMAL CELLS
Berry, M. N., & Friend, D. S. (1969) · The Journal of Cell Biology · doi:10.1083/jcb.43.3.506 · Cited by 4,424
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Treatment of the Crigler–Najjar Syndrome Type I with Hepatocyte Transplantation
Fox, I. J., Chowdhury, J. R., Kaufman, S. S., Goertzen, T. C., Chowdhury, N. R., Warkentin, P. I., Dorko, K., Sauter, B. V., & Strom, S. C. (1998) · New England Journal of Medicine · doi:10.1056/nejm199805143382004 · Cited by 1,023
Long-term storage of tissues by cryopreservation: critical issues
Karlsson, J. O. M., & Toner, M. (1996) · Biomaterials · doi:10.1016/0142-9612(96)85562-1 · Cited by 619
Lee, W. M. (1993) · New England Journal of Medicine · doi:10.1056/nejm199312163292508 · Cited by 546
Fulminant hepatic failure: Summary of a workshop
Hoofnagle, J. H., Carithers, R. L., Shapiro, C., & Ascher, N. (1995) · Hepatology · doi:10.1002/hep.1840210137 · Cited by 533
HEPATOCYTE TRANSPLANTATION AS A BRIDGE TO ORTHOTOPIC LIVER TRANSPLANTATION IN TERMINAL LIVER FAILURE
Strom, S. C., Fisher, R. A., Thompson, M. T., Sanyal, A. J., Cole, P. E., Ham, J. M., & Posner, M. P. (1997) · Transplantation · doi:10.1097/00007890-199702270-00014 · Cited by 518
HUMAN FETAL HEPATOCYTE TRANSPLANTATION IN PATIENTS WITH FULMINANT HEPATIC FAILURE
Habibullah, C. M., Syed, I. H., Qamar, A., & Taher-Uz, Z. (1994) · Transplantation · doi:10.1097/00007890-199410270-00016 · Cited by 301
Treatment of Hepatic Failure with ex Vivo Pig-Liver Perfusion Followed by Liver Transplantation
Chari, R. S., Collins, B. H., Magee, J. C., DiMaio, J. M., Kirk, A. D., Harland, R. C., McCann, R. L., Platt, J. L., & Meyers, W. C. (1994) · New England Journal of Medicine · doi:10.1056/nejm199407283310404 · Cited by 286
Liver transplantation in the management of fulminant hepatic failure
Emond, J. C., Aran, P. P., Whitington, P. F., Broelsch, C. E., & Baker, A. L. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90530-1 · Cited by 145
Cited by
Badylak, S. F., Taylor, D., & Uygun, K. (2011) · Annual Review of Biomedical Engineering · doi:10.1146/annurev-bioeng-071910-124743 · Cited by 1,041
Kuo, T. K., Hung, S., Chuang, C., Chen, C., Shih, Y. V., Fang, S. Y., Yang, V. W., & Lee, O. K. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.03.015 · Cited by 466
Human Hepatocyte Transplantation: Worldwide Results
Fisher, R. A., & Strom, S. C. (2006) · Transplantation · doi:10.1097/01.tp.0000231689.44266.ac · Cited by 445
Human hepatocyte transplantation: current experience and future challenges
Dhawan, A., Puppi, J., Hughes, R. D., & Mitry, R. R. (2010) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2010.44 · Cited by 362
Cell and tissue engineering for liver disease
Bhatia, S. N., Underhill, G. H., Zaret, K. S., & Fox, I. J. (2014) · Science Translational Medicine · doi:10.1126/scitranslmed.3005975 · Cited by 309
Use of differentiated pluripotent stem cells in replacement therapy for treating disease
Fox, I. J., Daley, G. Q., Goldman, S. A., Huard, J., Kamp, T. J., & Trucco, M. (2014) · Science · doi:10.1126/science.1247391 · Cited by 291
Human hepatocyte transplantation for liver disease: current status and future perspectives
Iansante, V, Mitry, R. R., Filippi, C., Fitzpatrick, E., & Dhawan, A. (2018) · Pediatric Research · doi:10.1038/pr.2017.284 · Cited by 225
Cell therapy for advanced liver diseases: repair or rebuild
Dwyer, B. J., Macmillan, M. T., Brennan, P. N., & Forbes, S. J. (2021) · Journal of Hepatology · doi:10.1016/j.jhep.2020.09.014 · Cited by 141
Liver tissue engineering and cell sources: issues and challenges
Palakkan, A. A., Hay, D. C., PR, A. K., TV, K., & Ross, J. A. (2013) · Liver International · doi:10.1111/liv.12134 · Cited by 130
Horslen, S. P., & Fox, I. J. (2004) · Transplantation · doi:10.1097/01.tp.0000113809.53415.c2 · Cited by 119
Macrophages as a Cell-Based Therapy for Liver Disease
Starkey Lewis, P. J., Moroni, F., & Forbes, S. J. (2019) · Seminars in Liver Disease · doi:10.1055/s-0039-1688502 · Cited by 36
Metadata
- Authors
- Bilir, B. M., Guinette, D., Karrer, F., Kumpe, D. A., Krysl, J., Stephens, J., McGavran, L., Ostrowska, A., & Durham, J.
- Venue
- Liver Transplantation
- Published
- 2000-01
- Volume
- 6
- Issue
- 1
- Pages
- 32-40
- ISSN
- 1527-6465 (ISSN-L)
- OpenAlex
- W2078240388
- Cited by
- 358
- References
- 24
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.